Back to Search
Start Over
Impact of PIK3CA mutation status on immune marker response and pCR in the WSG-ADAPT HER2+/HR+ phase II trial.
- Authors :
- Harbeck, Nadia
Nitz, Ulrike
Christgen, Matthias
Kates, Ronald E.
Braun, Michael Wilhelm
Kummel, Sherko
Schumacher, Claudia
Potenberg, Jochem
Malter, Wolfram
Augustin, Doris
Aktas, Bahriye
Forstbauer, Helmut
Tio, Joke
Kleine-Tebbe, Anke
Liedtke, Cornelia
de Haas, Sanne
Deurloo, Regula
Wuerstlein, Rachel
Kreipe, Hans Heinrich
Gluz, Oleg
Harbeck, Nadia
Nitz, Ulrike
Christgen, Matthias
Kates, Ronald E.
Braun, Michael Wilhelm
Kummel, Sherko
Schumacher, Claudia
Potenberg, Jochem
Malter, Wolfram
Augustin, Doris
Aktas, Bahriye
Forstbauer, Helmut
Tio, Joke
Kleine-Tebbe, Anke
Liedtke, Cornelia
de Haas, Sanne
Deurloo, Regula
Wuerstlein, Rachel
Kreipe, Hans Heinrich
Gluz, Oleg
- Publication Year :
- 2018
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1201319326
- Document Type :
- Electronic Resource